News
Activist investor Glenview Capital is reducing its stake in healthcare giant CVS Health following its first-quarter earnings ...
Transitions of care—moving patients from one care site to another—continues to be a challenge in healthcare. | Startup Kouper ...
Massachusetts Attorney General Andrea Joy Campbell is suing Woonsocket-based CVS Health for fraudulently charging the state’s Medicaid program more for prescription drugs than cash-paying ...
6h
Worcester Telegram on MSNState AG sues CVS over allegedly excluding MassHealth customers from discountsCampbell and attorneys general in Connecticut, Indiana and Oklahoma jointly filed a civil action after a whistleblower ...
The complaint alleged that through a discount card program with ScriptSave, CVS customers who paid in cash received discounts ...
Mass. Attorney General Campbell has filed a lawsuit against CVS for allegedly charging MassHealth higher costs for prescription drugs than cash-paying customers.
WPRI Providence on MSN22h
Campbell accuses CVS of unfair drug pricingMassachusetts Attorney General Andrea Joy Campbell is suing Woonsocket-based CVS Health for allegedly charging the state’s Medicaid program more for prescription drugs than cash-paying customers.
The House and Senate will need to reconcile their versions of the bill for it to become law — something that has eluded the ...
The U.S. Attorney’s Office for the Southern District of New York last week announced the resolution of two significant False Claims Act ...
Attorney General Andrea Campbell and a few of her peers sued CVS on Wednesday, alleging the pharmacy giant for years failed to provide Medicaid members with access to the same discount as cash-paying ...
4h
Zacks Investment Research on MSNQuidelOrtho Stock Gains Following Q1 Earnings Beat, Margins ExpandQuidelOrtho Corporation QDEL delivered adjusted earnings per share (EPS) of 74 cents in first-quarter 2025, up 68.2% year ...
Because price and margin headwinds exist predominantly in small-molecule oral tablets that are easy to produce, we expect Viatris’ future pipeline to focus more on complex generics—drugs that have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results